{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:44:01Z","timestamp":1793040241718,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NCI","award":["P30CA022453"],"award-info":[{"award-number":["P30CA022453"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11307-023-01877-8","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T15:02:12Z","timestamp":1701097332000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of Cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-4452","authenticated-orcid":false,"given":"Otto","family":"Muzik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Barger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huailei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathi","family":"Chamiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.acc.2019.08.005","volume":"95","author":"S Comai","year":"2020","unstructured":"Comai S, Bertazzo A, Brughera M, Crotti S (2020) Tryptophan in health and disease. Adv Clin Chem 95:165\u2013218","journal-title":"Adv Clin Chem"},{"issue":"3","key":"1877_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","volume":"34","author":"DH Munn","year":"2013","unstructured":"Munn DH, Mellor AL (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 34(3):137\u2013143","journal-title":"Trends Immunol"},{"issue":"22","key":"1877_CR3","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","volume":"18","author":"DA Wainwright","year":"2012","unstructured":"Wainwright DA, Balyasnikova IV, Chang AL et al (2012) IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res 18(22):6110\u20136121","journal-title":"Clin Cancer Res"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"173921","DOI":"10.1016\/j.ejphar.2021.173921","volume":"896","author":"M Ala","year":"2021","unstructured":"Ala M (2021) The footprint of kynurenine pathway in every cancer: a new target for chemotherapy. Eur J Pharmacol 896:173921","journal-title":"Eur J Pharmacol"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.jcbfm.9600199","volume":"26","author":"C Juh\u00e1sz","year":"2006","unstructured":"Juh\u00e1sz C, Chugani DC, Muzik O et al (2006) In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 26:345\u2013357","journal-title":"J Cereb Blood Flow Metab"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11307-009-0225-0","volume":"11","author":"CEA Batista","year":"2009","unstructured":"Batista CEA, Juh\u00e1sz C, Muzik O et al (2009) Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol Imaging Biol 11:460\u2013466","journal-title":"Mol Imaging Biol"},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2967\/jnumed.111.097881","volume":"53","author":"B Alkonyi","year":"2012","unstructured":"Alkonyi B, Barger GR, Mittal S et al (2012) Accurate identification of recurrent gliomas from radiation injury by kinetic analysis of alpha-[11C]methyl-L-tryptophan PET. J Nucl Med 53:1058\u20131064","journal-title":"J Nucl Med"},{"key":"1877_CR8","doi-asserted-by":"publisher","unstructured":"Juh\u00e1sz C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S (2014) Comparison of amino acid positron emission tomographic\u00a0radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging 13. https:\/\/doi.org\/10.2310\/7290.2014.00015","DOI":"10.2310\/7290.2014.00015"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/neuonc\/noy169","volume":"21","author":"F John","year":"2019","unstructured":"John F, Bosnyak E, Robinette NL et al (2019) Multimodal imaging-defined subregions in newly-diagnosed glioblastoma: impact on overall survival. Neuro-Oncology 21:264\u2013273","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1877_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004647-200001000-00002","volume":"20","author":"DC Chugani","year":"2000","unstructured":"Chugani DC, Muzik O (2000) Alpha[C-11]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 20(1):2\u20139","journal-title":"J Cereb Blood Flow Metab"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nucmedbio.2016.03.001","volume":"43","author":"J Henrottin","year":"2016","unstructured":"Henrottin J, Lemaire C, Egrise D et al (2016) Fully automated radiosynthesis of N1-[(18F)]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging. Nucl Med Biol 43:379\u2013389","journal-title":"Nucl Med Biol"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11307-016-1024-z","volume":"19","author":"Y Xin","year":"2017","unstructured":"Xin Y, Cai H (2017) Improved radiosynthesis and biological evaluations of L- and D-1-[18F]fluoroethyl-tryptophan for PET imaging of IDO-mediated kynurenine pathway of tryptophan metabolism. Mol Imaging Biol 19:589\u2013598","journal-title":"Mol Imaging Biol"},{"key":"1877_CR13","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11307-019-01327-4","volume":"21","author":"Y Xin","year":"2019","unstructured":"Xin Y, Gao X, Liu L, Ge WP, Jain MK, Cai H (2019) Evaluation of L-1-[18F]fluoroethyl-tryptophan for PET imaging of cancer. Mol Imaging Biol 21:1138\u20131146","journal-title":"Mol Imaging Biol"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.116.179994","volume":"58","author":"SK Michelhaugh","year":"2017","unstructured":"Michelhaugh SK, Muzik O, Guastella AR et al (2017) Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and \u03b1-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts. J Nucl Med 58:208\u2013213","journal-title":"J Nucl Med"},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11307-019-01430-6","volume":"22","author":"F John","year":"2020","unstructured":"John F, Muzik O, Mittal S, Juh\u00e1sz C (2020) Fluorine-18-labeled PET radiotracers for imaging tryptophan uptake and metabolism: a systematic review. Mol Imaging Biol 22:805\u2013819","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"1877_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1227\/NEU.0b013e31828cf945","volume":"72","author":"K Mitsuka","year":"2013","unstructured":"Mitsuka K, Kawataki T, Satoh E, Asahara T, Horikoshi T, Kinouchi H (2013) Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas. Neurosurgery 72(6):1031\u20131038","journal-title":"Neurosurgery"},{"issue":"2","key":"1877_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-018-2869-6","volume":"139","author":"AR Guastella","year":"2018","unstructured":"Guastella AR, Michelhaugh SK, Klinger NV et al (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neuro-Oncol 139(2):239\u2013249","journal-title":"J Neuro-Oncol"},{"issue":"7-8","key":"1877_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jlcr.4027","volume":"66","author":"H Jiang","year":"2023","unstructured":"Jiang H, Guo Y, Cai H et al (2023) Automated radiosynthesis of 1-(2-[18F]fluoroethyl)-L-tryptophan ([18F]FETrp) for positron emission tomography (PET) imaging of cancer in humans. J Labelled Comp Radiopharm 66(7-8):180\u2013188","journal-title":"J Labelled Comp Radiopharm"},{"issue":"12","key":"1877_CR19","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.122.264063","volume":"63","author":"LK Shiyam Sundar","year":"2022","unstructured":"Shiyam Sundar LK, Yu J, Muzik O et al (2022) Fully automated, semantic segmentation of whole-body 18F-FDG PET\/CT images based on data-centric artificial intelligence. J Nucl Med 63(12):1941\u20131948","journal-title":"J Nucl Med"},{"key":"1877_CR20","first-page":"538","volume":"37","author":"MG Stabin","year":"1996","unstructured":"Stabin MG (1996) MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 37:538\u2013546","journal-title":"J Nucl Med"},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00004032-200309000-00006","volume":"85","author":"MG Stabin","year":"2003","unstructured":"Stabin MG, Siegel JA (2003) Physical models and dose factors for use in internal dose assessment. Health Phys 85:294\u2013310","journal-title":"Health Phys"},{"key":"1877_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12880-016-0143-y","volume":"16","author":"B Quinn","year":"2016","unstructured":"Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer LT (2016) Radiation dosimetry of 18F-FDG PET\/CT: incorporating exam-specific parameters in dose estimates. BMC Med Imaging 16:41","journal-title":"BMC Med Imaging"},{"issue":"8","key":"1877_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00262-020-02556-1","volume":"69","author":"LD de Hosson","year":"2020","unstructured":"de Hosson LD, Takkenkamp TJ, Kats-Ugurlu G et al (2020) Neuroendocrine tumours and their microenvironment. Cancer Immunol Immunother 69(8):1449\u20131459","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1877_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/ml500385d","volume":"6","author":"J Henrottin","year":"2015","unstructured":"Henrottin J, Zervosen A, Lemaire C et al (2015) N(1)-Fluoroalkyltryptophan analogues: synthesis and in vitro study as potential substrates for indoleamine 2,3-dioxygenase. ACS Med Chem Lett 6(3):260\u2013265","journal-title":"ACS Med Chem Lett"},{"key":"1877_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coi.2021.03.005","volume":"70","author":"M Platten","year":"2021","unstructured":"Platten M, Friedrich M, Wainwright DA, Panitz V, Opitz CA (2021) Tryptophan metabolism in brain tumors - IDO and beyond. Curr Opin Immunol 70:57\u201366","journal-title":"Curr Opin Immunol"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cotox.2017.01.012","volume":"2","author":"S Safe","year":"2017","unstructured":"Safe S, Cheng Y, Jin UH (2017) The aryl hydrocarbon receptor (AhR) as a drug target for cancer chemotherapy. Curr Opin Toxicol 2:24\u201329","journal-title":"Curr Opin Toxicol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01877-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:15:15Z","timestamp":1706616915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01877-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01877-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3355828\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was supported by the Karmanos Cancer Institute SRIG and the National Cancer Institute (P30CA022453). No other potential conflict of interest relevant to this article was reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}